Donald Trump’s health policy agenda has taken a step back from his initial plans to slash U.S. drug prices and repeal the Affordable Care Act. This decision has left a void in his approach to healthcare reform, with some former White House officials suggesting that the policy ideas are still present but implementing them could lead to messy battles.

One such official, Joe Grogan, has indicated that if Trump were to return to office, Republicans would need to address President Biden’s signature drug pricing law and the expanded Affordable Care Act subsidies. This would involve either repealing or revisiting these policies, which could prove to be a challenging and contentious process.

The push to revisit these healthcare policies comes at a time when the healthcare landscape in the United States is constantly evolving. With rising drug prices and ongoing debates surrounding the Affordable Care Act, there is a growing need for comprehensive and sustainable healthcare reform.

However, access to the full details of this article is restricted to STAT+ subscribers. To unlock this exclusive content and gain access to daily intelligence on Capitol Hill and the life sciences industry, interested readers are encouraged to subscribe to STAT+.

In conclusion, the future of healthcare policy in the United States remains uncertain, with key decisions and reforms hanging in the balance. As the debate over drug prices and healthcare access continues to unfold, it is essential for policymakers to navigate these challenges with a focus on improving the overall well-being of all Americans.